Cetera Investment Advisers
MBOT icon

Cetera Investment Advisers’s Microbot Medical MBOT Stock Holding History

Cetera Investment Advisers’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.4K Buy
43,812
+1,400
+3% +$2.85K ﹤0.01% 4691
2026
Q1 		$102K Buy
42,412
+13,099
+45% +$29.3K ﹤0.01% 4445
2025
Q4 		$58.6K Buy
29,313
+8,201
+39% +$19.4K ﹤0.01% 4486
2025
Q3 		$64.4K Buy
+21,112
New +$65.8K ﹤0.01% 4401

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Cetera Investment Advisers's MBOT Position: Q2 2026 in Review

Cetera Investment Advisers increased its Microbot Medical (MBOT) stake by 3.3% in Q2 2026, buying an estimated $2.85K and bringing the position to 43,812 shares worth $85.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4691.

Cetera Investment Advisers first reported a position in MBOT in Q3 2025 and has held it in 4 quarters since. The position peaked at $102K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Cetera Investment Advisers held 43,812 shares of Microbot Medical worth $85.4K as of Q2 2026.
  • Cetera Investment Advisers bought 1,400 Microbot Medical shares in Q2 2026, an estimated $2.85K.
  • Microbot Medical made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4691 holding.
  • Cetera Investment Advisers first reported a position in Microbot Medical in Q3 2025 and has held it in 4 quarters since.
  • Cetera Investment Advisers's Microbot Medical position peaked at $102K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.